The Scientist

» drug development and immunology

Most Recent

image: Screening Goes In Silico

Screening Goes In Silico

By | February 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: Thanks for the Memories

Thanks for the Memories

By | February 1, 2015

B and T cells may be the memory masters of the immune system, but research reveals that other cells can be primed by pathogens, too.

1 Comment

image: Viral Virtuosos

Viral Virtuosos

By | February 1, 2015

New understanding of noncoding RNAs may solve a long-standing puzzle about how viruses orchestrate lifelong infections.  

3 Comments

image: Drug Stimulates Brown Fat

Drug Stimulates Brown Fat

By | January 28, 2015

A small study finds that an approved medication increases metabolic rate and the activity of thermogenic brown fat in men.

2 Comments

image: Interferon Discoverer Dies

Interferon Discoverer Dies

By | January 26, 2015

Jean Lindemann, the virologist who helped figure out that interferons were responsible for anti-viral responses, has passed away at age 90.

0 Comments

image: Inflammation Overdrive

Inflammation Overdrive

By | January 15, 2015

Experimental vaccines that specifically boost T helper cells lead to immunopathology and death in mice.

2 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

Popular Now

  1. A Coral to Outlast Climate Change
  2. Antarctica Is Turning Green
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. Science Celebrities: Where Are the Women?
AAAS